Trial Profile
Special Survey Long-term Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2014
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 07 Apr 2010 Primary outcome amended as reported by ClinicalTrials.gov.
- 01 May 2009 Planned number of patients changed from 300 to 385 as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.